What’s STIPED about?
Welcome to the website of STIPED!
We are a new European project that aims to offer a new treatment option for you and other healthy children and adolescents and those affected by Attention Deficit Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD).
In the next five years STIPED will recruit 517 children and adolescents aged from 10 to 20 years (10 – 18 years old in ADHD study and 10 – 20 years old in ASD study) from across Europe (including Germany, France and Portugal).
The new treatment strategy developed in STIPED is based on innovative, effective and safe brain stimulation methods using transcranial direct current stimulation (tDCS), a non-invasive technique that delivers low amplitude direct currents to the brain. If you want to learn more about this, have a look at our brain stimulation section.
STIPED also introduces a completely novel concept of mental health disorders therapy based on individualization of treatment, the use of a home-based treatment device (an electrode cap), and a telemental health service enabling remote control of safety, stimulation settings, and continuous monitoring of clinical symptoms. This will sometime in the future give you the opportunity to use this novel device and its benefits at home while eating breakfast, before you go off to school.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme and involves scientific collaboration between 11 universities, clinics and companies across Europe. The project runs over five years until 31st December 2021. It is coordinated by the Christian-Albrechts-University of Kiel, Germany (till end of 2018) and Evangelisches Klinikum Bethel (EvKB), Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Bielefeld (starting with January 2019).